Block Drug Company, Inc.

Frank J Sena

Kuo-Chen Yeh

Michael C Alfano

Manuel M Roque

Phil J Oths

Neil J Napolitano

Richard I Vogel

A solid dosage form for relieving xerostomia symptoms comprising a lubricating polymer comprising polyethylene oxide and a sialogogue in a pharmaceutically acceptable, substantially non-cariogenic, carrier.

Solid form xerostomia product

Omega-3, 20-22 carbon atom, hexa- or penta-unsaturated fatty acids are used in the treatment of periodontal disease.

Treatment of periodontal disease

Synergistic compositions comprising an antioxidant and an arylpropionic, non-steroidal anti-imflammatory drug used to treat certain diseases are disclosed. The compositions inhibit production of arachidonic acid cascade end-products which have been implicated as causes of tissue-destruction in periodontal disease. The compositions are administered in combination with a carrier, which may be a mucosal-tenacious polymer selected from the groups of semi-solid pastes, gels, ointments, liquids or films.

Growing community of inventors

Brooklyn, NY, United States of America

Frank J Sena